• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

intersectent

Intersect ENT appoints new CFO

November 27, 2019 By Danielle Kirsh

Intersect ENT (NSDQ:XENT) today said it appointed Richard Meier as executive VP and chief financial officer, effective immediately. Prior to joining Intersect ENT, Meier was a chief financial officer and a senior executive at Owens & Minor. He has held a number of executive leadership roles at Teleflex, Advanced Medical Optics (now part of Abbott Labs) […]

Filed Under: Business/Financial News, Featured Tagged With: intersectent, Personnel Moves

Intersect ENT’s Q3 beats on sales, misses on earnings

November 1, 2019 By Brad Perriello

Intersect ENT (NSDQ:XENT) this morning posted wider-than-expected losses but topped the consensus sales estimate with its third-quarter results. Menlo Park, Calif.-based Intersect reported losses of -$12.8 million, or -41¢ per share, on sales of $24.1 million for the three months ended Sept. 30. Get the full story at our sister site, Drug Delivery Business News

Filed Under: Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: intersectent

Intersect ENT’s Ascend study misses endpoint

October 7, 2019 By Sean Whooley

Intersect ENT (NSDQ:XENT) shares plunged today after the company said it failed to meet the primary endpoint in a study of its Ascend investigational drug-coated sinus balloon. The 70-person, randomized, double-blind trial was designed to compared treatment with Intersect ENT’s DCB when randomized against an uncoated balloon control. The study missed the primary endpoint, frontal sinus […]

Filed Under: Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA), Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance Tagged With: intersectent, svbleerink

FDA approves delivery system for Intersect ENT’s Propel implant

July 26, 2019 By Brad Perriello

Intersect ENT (NSDQ:XENT) said today that it won FDA approval for a new delivery system for its Propel Mini steroid-eluting sinus implant. The Menlo Park, Calif.-based company said the straight delivery system is designed to place the mometasone furoate-eluting Propel Mini in the ethmoid sinus behind the nasal bridge. The SDS is slated to hit […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance Tagged With: intersectent

Intersect ENT lures Hologic’s West for CEO | Personnel Moves, June 28, 2019

June 28, 2019 By Brad Perriello

Intersect ENT (NSDQ:XENT) yesterday named Hologic (NSDQ:HOLX) executive Tom West to be its new president & CEO effective July 22. West, who has been president of Hologic’s diagnostics solutions division since October 2014, is a Johnson & Johnson (NYSE:JNJ) veteran, Menlo Park, Calif.-based Intersect ENT said. The company in May tapped lead director Kieran Gallahue to […]

Filed Under: Business/Financial News, Featured Tagged With: Apollo Endosurgery, Globus Medical, intersectent, Personnel Moves, Pfizer

Wright Medical creates digital arm, promotes Asper to chief digital officer | Personnel Moves – May 7, 2019

May 7, 2019 By Fink Densford

Wright Medical (NSDQ:WMGI) said today that it is creating a new digital division and that it is promoting strategy, tech & corporate dev senior VP Jason Asper to chief digital officer. The new CDO title comes alongside Asper’s existing responsibilities, Amsterdam-based Wright Medical said. The new digital division will focus on the company’s digital surgery strategy […]

Filed Under: Business/Financial News Tagged With: Abbott, Avanos Medical (formerly Halyard Health), CHF Solutions Inc., Ekso Bionics, iCad Inc., Insulet, intersectent, Medtronic, stericycle, theromics, wrightmedical

Intersect ENT posts mixed-bag Q1 earnings

May 6, 2019 By Fink Densford

Intersect ENT (NSDQ:XENT) today posted first quarter earnings that topped sales expectations but missed loss-per-share consensus on Wall Street. The Menlo Park, Calif.-based company posted losses of $10.8 million, or 35¢ per share, on sales of $26.7 million for the three months ended March 31, seeing losses grow 76.1% while sales grew 7.9% compared with the […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: intersectent

Intersect ENT wins preliminary CMS reimbursement code

April 30, 2019 By Nancy Crotti

Shares in Intersect ENT (NSDQ:XENT) got a boost yesterday on news that the Centers for Medicare and Medicaid Services (CMS) had assigned the company’s Sinuva corticosteroid-eluting sinus implant a preliminary J-code. Intersect ENT stock, which had been bumping along just under $30 per share last week, jumped to $33.13 per share at Monday’s market open, then […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Medicare, News Well, Wall Street Beat Tagged With: Centers for Medicare and Medicaid Services (CMS), intersectent, svbleerink

Intersect ENT shares dip despite street-beating Q4, 2018 earnings

February 26, 2019 By Fink Densford

Shares in Intersect ENT (NSDQ:XENT) have fallen slightly today despite the medical device maker released fourth quarter and full year 2018 earnings that met consensus expectations from analysts on Wall Street. The Menlo Park, Calif.-based company posted losses of $5 million, or 16¢ per share, on sales of approximately $32.8 million for the three months ended […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: intersectent

Dexcom Q4 prelims top consensus | Wall Street Beat

January 7, 2019 By Sarah Faulkner

Dexcom (NSDQ:DXCM)  topped estimates on Wall Street today with preliminary results for its fourth-quarter financial results. The San Diego, Calif.-based company said it expects to report $331 million in sales for the quarter ended Dec. 31 – up at least 50% from the same period last year. Get the full story at our sister site, Drug […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Wall Street Beat Tagged With: apyxmedical, Bovie Medical Corp., Dexcom, intersectent, TransEnterix

Intersect ENT launches trial of drug-coated sinus balloon

December 17, 2018 By Sarah Faulkner

Intersect ENT (NSDQ:XENT) said today that it enrolled the first patient in a trial of its Ascend drug-coated sinus balloon. The Menlo Park, Calif.-based company’s device is designed to deliver mometasone furoate directly to a person’s sinuses at the time of dilation. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Otolaryngology/Ear, Nose & Throat (ENT), Pharmaceutical, Wall Street Beat Tagged With: intersectent

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 6
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy